patient_id	diagnosis	specific_diagnosis	lab_id	specimen_type	run_type	inhibitor	replicant	well_concentration	normalized_viability	time_of_read	id
2621	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	NA	16-00332	Peripheral Blood	Standard	Gefitinib	1	10	67.8372834247072	24	2621-Gefitinib-1-16-00332
2621	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	NA	16-00332	Peripheral Blood	Standard	Gefitinib	1	3.33333	86.1382138415147	24	2621-Gefitinib-1-16-00332
2621	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	NA	16-00332	Peripheral Blood	Standard	Gefitinib	1	1.11111	96.5958883654046	24	2621-Gefitinib-1-16-00332
2621	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	NA	16-00332	Peripheral Blood	Standard	Gefitinib	1	0.37037	93.2934648315446	24	2621-Gefitinib-1-16-00332
2621	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	NA	16-00332	Peripheral Blood	Standard	Gefitinib	1	0.123457	97.2838932682921	24	2621-Gefitinib-1-16-00332
2621	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	NA	16-00332	Peripheral Blood	Standard	Gefitinib	1	0.041152	129.069719781694	24	2621-Gefitinib-1-16-00332
2621	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	NA	16-00332	Peripheral Blood	Standard	Gefitinib	1	0.013717	186.311727701934	24	2621-Gefitinib-1-16-00332
